We are live on ! Find out more
INVA icon

Innoviva

197 hedge funds and large institutions have $894M invested in Innoviva in 2023 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 63 increasing their positions, 78 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more call options, than puts

Call options by funds: $328K | Put options by funds: $225K

23% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 22

16% more capital inflows, than outflows

Capital inflows: $73.3M | Capital outflows: $63.4M

5.14% more ownership

Funds ownership: 102.15% → 107.28% (+5.1%)

3% more funds holding

Funds holding: 192 → 197 (+5)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

19% less repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 78

Holders
197
Holders Change
+5
Holders Change %
+2.6%
% of All Funds
3.08%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
27
Increased
63
Reduced
78
Closed
22
Calls
$328​K
Puts
$225​K
Net Calls
+$103​K
Net Calls Change
+$136​K

INVA Hedge Fund Activity: Q2 2023 in Review

197 of the 6,386 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q2 2023, worth a combined $894M — up 14% from $788M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new INVA positions and 22 closed out — a net gain of 5 holders — while 63 added to existing stakes and 78 trimmed.

The largest buyer was Russell Investments Group, adding an estimated $11M. The largest seller was Pacer Advisors, cutting an estimated $8.73M.

  • 197 institutional investors held Innoviva (INVA) as of Q2 2023, up from 192 in Q1 2023.
  • Funds reported $894M of Innoviva stock for Q2 2023, up 14% quarter-over-quarter.
  • 27 funds opened new Innoviva positions in Q2 2023 and 22 closed out, a net change of +5 holders.
  • The largest Innoviva buyer in Q2 2023 was Russell Investments Group, an estimated $11M added.
  • The largest Innoviva seller in Q2 2023 was Pacer Advisors, an estimated $8.73M sold.

Based on aggregated 13F filings for Q2 2023.